{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-018072","form_type":"8-K","ticker":"ATXI","cik":"0001644963","company_name":"AVENUE THERAPEUTICS, INC.","filed_at":"2024-05-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.402344+00:00","generated_at":"2026-06-01T09:13:06.281956+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Avenue Therapeutics regains Nasdaq compliance on equity rule; remains under Panel Monitor until May 2025","bullets":["Notified by Nasdaq on May 21, 2024, that it meets minimum stockholders' equity requirement for continued listing.","Previously disclosed listing matter is now closed.","Subject to a Panel Monitor for one year (through May 21, 2025).","If equity rule is not satisfied during monitoring, loses compliance plan option and must request a hearing.","Company trades as ATXI on Nasdaq Capital Market."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-018072","json":"https://secwatch.observer/filing/0001437749-24-018072.json","markdown":"https://secwatch.observer/filing/0001437749-24-018072.md","text":"https://secwatch.observer/filing/0001437749-24-018072.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1644963/000143774924018072/0001437749-24-018072-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1644963/000143774924018072/atxi20240522_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T09:13:06.281956+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}